Today: 9 June 2026
Browse Category

NYSE:EAT 11 December 2025 - 11 February 2026

Texas Roadhouse stock rebounds after Truist downgrade — what could move TXRH next week

Texas Roadhouse stock rebounds after Truist downgrade — what could move TXRH next week

Texas Roadhouse shares rose 0.8% to $184.13 Wednesday, recovering some ground after a 2.7% drop Tuesday following a Truist downgrade. Truist cut its rating to hold, citing concerns that beef inflation could persist into 2027 and limit margin gains. The company reports fourth-quarter earnings on Feb. 19. Options trading showed heightened volatility ahead of the results.
11 February 2026
·····
Chili’s jabs at McDonald’s ‘value meals’ with $10.99 deal as diners watch prices

Chili’s jabs at McDonald’s ‘value meals’ with $10.99 deal as diners watch prices

Chili’s Grill & Bar promoted a $10.99 burger meal on X this week, criticizing fast-food value bundles as lacking real value. The campaign comes as restaurant brands compete for price-sensitive diners. Chili’s parent Brinker International has gained ground with lower-income customers, according to Reuters. Separately, Chili’s closed its Orlando airport location after 22 years, airport officials said.
2 January 2026
·
Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International shares rose 7% to $146 intraday on December 11, 2025, after outperforming short-term trading models and drawing institutional interest. The stock remains 24% below its 52-week high and 46% above its low. Chili’s same-store sales have grown by high teens to low 20% in recent quarters, driving improved margins and over $500 million in debt reduction.
11 December 2025
··

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop